Subclinical atherosclerosis in patients with psoriatic arthritis: A case-control study. Preliminary data;Aterosclerosi subclinica in pazienti con artrite psoriasica: Studio caso-controllo. Dati preliminari

Reumatismo

Volumn 61, Issue 4, 2009, Pages 298-305

  Contessa, C ^a   Ramonda, Roberta ^a   Lo Nigro, A ^a   Modesti, V ^a   Lorenzin, M ^a   Puato, M ^a   Zanon, M ^a   Balbi, G ^a   Doria, A ^a   Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endothelial dysfunction; Intima media thickness; Psoriatic arthritis; Subclinical atherosclerosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; MALE; PREVALENCE; PSORIATIC ARTHRITIS; RISK FACTOR; UNIVARIATE ANALYSIS;

ARTHRITIS, PSORIATIC; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 75749121475     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Punzi L. Artrite Psoriasica. In: Malattie Reumatiche. Todesco S, Gambari PF, Punzi L eds McGraw-Hill, Milano 2007; 175-181.
2. Del Rincón I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003; 48: 1833-40.
3. Hahn BH, Grossman J, Chen W, McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007; 28: 69-75.
4. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rhematol 2006; 2: 99-106.
5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
6. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
7. Shoenfeld Y, Sherer Y, Harats D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001; 22: 293-5.
8. Jonsson SW, Backman C, Johnson O, Karp K, Lundström E, Sundqvist KG, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597-602.
9. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868-72.
10. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factor. Arthritis Rheum 2007; 57: 1074-80.
11. Moll JMN, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 51-78.
12. Frauchiger B, Schmid P, Roedel C, et al. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 2001; 32: 836-41.
13. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
14. Sutton-Tyrrell K, Wolfson SK, Thomson T, Kelsey SF. Measurement of variability in duplex-scan assessment of carotid artery. Stroke 1992; 23: 215-20.
15. Carotti M, Salaffi F, Mangiacotti M, Cerioni A, Giuseppetti GM, Grassi W. Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo 2007; 59: 38-49.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
17. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004; 109 (Suppl. 1): 33-88.
18. Salonen R, Salonen JT: Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-31.
19. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 2008; 35: 877-82.
20. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factor. Arthritis Rheum 2007; 57: 287-93.
21. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, et al. Lack of echocardiographic and doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factor. Semin Arthritis Rheum 2006; 35: 333-9.
22. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol 2006; 33: 2167-72.
23. Tam LS, Tomlinson B, Chu TTW, Li M, Leung YY, Kwok LW, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls- the role of inflammation. Rheumatology 2008; 47: 718-23.
24. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
25. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br. J. Dermatology 2007; 156: 271-6.
26. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
27. Escárcega RO, García-Carrasco M, Fuentes-Alexandro S, Jara LJ, Rojas-Rodriguez J, Escobar-Linares LE, et al. Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosusrelated coronary disease. Autoimmun Rev 2006; 6: 48-53.
28. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-14.
29. Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. II. Prognostic indicators for death. Arthritis Rheum 1998; 41: 1103-10.
30. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 2001; 37: 1047-52.
31. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Salvetti A. Endothelial disfunction in Hypertension. J Nephrol 2000; 13: 205-10.
32. Lerman A, Zeiher M. Endothelial function, cardiac events. Circulation 2005; 111: 363-8.
33. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertension 2005; 23: 233-46.